CI
LLY icon

CX Institutional’s Eli Lilly LLY Stock Holding History

CX Institutional’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.6M Buy
35,493
+1,675
+5% +$1.71M 1.23% 17
2026
Q1 		$31.1M Buy
33,818
+4,543
+16% +$4.61M 0.95% 22
2025
Q4 		$31.5M Sell
29,275
-1,633
-5% -$1.56M 0.94% 26
2025
Q3 		$23.6M Buy
30,908
+2,191
+8% +$1.63M 0.72% 32
2025
Q2 		$22.4M Buy
28,717
+1,494
+5% +$1.16M 0.78% 29
2025
Q1 		$22.5M Buy
27,223
+3,600
+15% +$3M 0.85% 27
2024
Q4 		$18.2M Buy
23,623
+4,452
+23% +$3.69M 0.72% 33
2024
Q3 		$17M Sell
19,171
-408
-2% -$367K 0.75% 30
2024
Q2 		$17.7M Sell
19,579
-944
-5% -$755K 0.83% 30
2024
Q1 		$16M Buy
20,523
+1,429
+7% +$1.02M 0.77% 33
2023
Q4 		$11.1M Sell
19,094
-2,903
-13% -$1.69M 0.6% 46
2023
Q3 		$11.8M Sell
21,997
-8,330
-27% -$4.29M 0.65% 46
2023
Q2 		$14.2M Buy
30,327
+50
+0.2% +$21K 0.74% 29
2023
Q1 		$10.6M Buy
30,277
+14,029
+86% +$4.73M 0.56% 42
2022
Q4 		$5.94M Buy
16,248
+10,183
+168% +$3.61M 0.36% 67
2022
Q3 		$1.96M Buy
6,065
+705
+13% +$223K 0.14% 185
2022
Q2 		$1.74M Buy
5,360
+625
+13% +$188K 0.13% 187
2022
Q1 		$1.36M Buy
4,735
+412
+10% +$106K 0.11% 194
2021
Q4 		$1.19M Buy
4,323
+88
+2% +$22.3K 0.09% 187
2021
Q3 		$979K Sell
4,235
-42
-1% -$10.4K 0.08% 215
2021
Q2 		$982K Sell
4,277
-9,808
-70% -$1.97M 0.08% 201
2021
Q1 		$2.63M Buy
14,085
+3,351
+31% +$655K 0.24% 105
2020
Q4 		$1.81M Sell
10,734
-1,027
-9% -$153K 0.17% 163
2020
Q3 		$1.74M Buy
11,761
+582
+5% +$90.1K 0.19% 146
2020
Q2 		$1.83M Buy
11,179
+260
+2% +$39.9K 0.24% 115
2020
Q1 		$1.51M Buy
10,919
+8,293
+316% +$1.14M 0.25% 88
2019
Q4 		$345K Sell
2,626
-41
-2% -$4.75K 0.06% 169
2019
Q3 		$298K Sell
2,667
-1,318
-33% -$147K 0.05% 195
2019
Q2 		$441K Buy
3,985
+427
+12% +$50.3K 0.07% 168
2019
Q1 		$462K Buy
3,558
+1,114
+46% +$135K 0.08% 161
2018
Q4 		$283K Buy
+2,444
New +$273K 0.06% 151

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CX Institutional's LLY Position: Q2 2026 in Review

CX Institutional increased its Eli Lilly (LLY) stake by 5% in Q2 2026, buying an estimated $1.71M and bringing the position to 35,493 shares worth $42.6M. The position accounts for 1.23% of the portfolio, ranked #17.

CX Institutional first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 1,085 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CX Institutional held 35,493 shares of Eli Lilly worth $42.6M as of Q2 2026.
  • CX Institutional bought 1,675 Eli Lilly shares in Q2 2026, an estimated $1.71M.
  • Eli Lilly made up 1.23% of CX Institutional's portfolio in Q2 2026, its #17 holding.
  • CX Institutional first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
  • 1,085 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.